Labcorp Long-Term Investments 2010-2024 | LH

Labcorp long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Labcorp long-term investments for the quarter ending December 31, 2024 were $0.016B, a 39.41% decline year-over-year.
  • Labcorp long-term investments for 2024 were $0.016B, a 39.41% decline from 2023.
  • Labcorp long-term investments for 2023 were $0.027B, a 59.06% decline from 2022.
  • Labcorp long-term investments for 2022 were $0.066B, a 7.88% increase from 2021.
Labcorp Annual Long-Term Investments
(Millions of US $)
2024 $16
2023 $27
2022 $66
2021 $61
2020 $74
2019 $85
2018 $61
2017 $58
2016 $58
2015 $58
2014 $93
2013 $89
2012 $78
2011 $77
2010 $79
2009 $71
Labcorp Quarterly Long-Term Investments
(Millions of US $)
2024-12-31 $16
2024-09-30 $17
2024-06-30 $18
2024-03-31 $18
2023-12-31 $27
2023-09-30 $40
2023-06-30 $67
2023-03-31 $66
2022-12-31 $66
2022-09-30 $64
2022-06-30 $58
2022-03-31 $62
2021-12-31 $61
2021-09-30 $62
2021-06-30 $82
2021-03-31 $85
2020-12-31 $74
2020-09-30 $71
2020-06-30 $72
2020-03-31 $67
2019-12-31 $85
2019-09-30 $86
2019-06-30 $87
2019-03-31 $67
2018-12-31 $61
2018-09-30 $58
2018-06-30 $59
2018-03-31 $58
2017-12-31 $58
2017-09-30 $65
2017-06-30 $67
2017-03-31 $58
2016-12-31 $58
2016-09-30 $60
2016-06-30 $62
2016-03-31 $61
2015-12-31 $58
2015-09-30 $62
2015-06-30 $69
2015-03-31 $89
2014-12-31 $93
2014-09-30 $95
2014-06-30 $97
2014-03-31 $87
2013-12-31 $89
2013-09-30 $87
2013-06-30 $88
2013-03-31 $87
2012-12-31 $78
2012-09-30 $81
2012-06-30 $79
2012-03-31 $80
2011-12-31 $77
2011-09-30 $75
2011-06-30 $79
2011-03-31 $83
2010-12-31 $79
2010-09-30 $80
2010-06-30 $71
2010-03-31 $69
2009-12-31 $71
2009-09-30 $75
2009-06-30 $69
2009-03-31 $64
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.029B $13.009B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47